Recommended Topic Related To:


"National Institutes of Health (NIH) scientists studying an emerging coronavirus have found that a combination of two licensed antiviral drugs, ribavirin and interferon-alpha 2b, can stop the virus from replicating in laboratory-grown cells. These"...


How Supplied


Tonsillitis and/or Pharyngitis

MOXATAG (amoxicillin extended-release tablets) is a penicillin-class antibacterial indicated for the treatment of tonsillitis and/or pharyngitis secondary to Streptococcus pyogenes (S. pyogenes) in adults and pediatric patients 12 yrs and older.

To reduce the development of drug-resistant bacteria and maintain the effectiveness of MOXATAG (amoxicillin extended-release tablets) and other antibacterial drugs, MOXATAG (amoxicillin extended-release tablets) should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.


Tonsillitis and/or Pharyngitis

The recommended dose of MOXATAG (amoxicillin extended-release tablets) is 775 mg once daily taken within 1 hour of finishing a meal for 10 days. The full 10-day course of therapy should be completed for effective treatment of tonsillitis and/or pharyngitis secondary to S. pyogenes.

Do not chew or crush tablet.


Dosage Forms And Strengths

775 mg blue film-coated, oval-shaped tablets printed with "MB-111" on one side in black edible ink.

MOXATAG (amoxicillin extended-release tablets) tablets for oral administration are provided as blue film- coated, oval-shaped tablets that contain 775 mg of amoxicillin as the trihydrate. The tablets are printed with "MB-111" on one side in black edible ink. MOXATAG (amoxicillin extended-release tablets) is packaged in bottles and blister cards as follows:

  • Bottles of 30............................................NDC [11042-###-##]
  • 10 Tablet Card (1 tablet per blister cavity)..............NDC [11042-###-##]


Store at 25 C (77 F); excursions permitted to 15-30 C (59-86 F) [See USP Controlled Room Temperature.]

CLINITEST is a registered trademark of Miles, Inc. CLINISTIX is a registered trademark of Bayer Corporation. MOXATAG (amoxicillin extended-release tablets) is a trademark of MiddleBrook Pharmaceuticals, Inc.,MiddleBrook Pharmaceuticals, Inc. Germantown, Maryland 20876 USA. FDA Rev date: 1/23/2008

Last reviewed on RxList: 2/8/2008
This monograph has been modified to include the generic and brand name in many instances.

How Supplied

Moxatag - User Reviews

Moxatag User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Moxatag sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Women's Health

Find out what women really need.